Northwestern University Human Resources
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Pith Moromo 2: Cohort to Study Health Consequences of Food and Nutrition Insecurity During Pregnancy and Lactation
Completed
- Conditions
- Food InsecurityNutritionMaternal and Child HealthHIV
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 371
- Registration Number
- NCT02974972
- Locations
- 🇺🇸
Northwestern University, Evanston, Illinois, United States
Implementing Resistance Exercise to Reduce Frailty for Older Adult
Not Applicable
Completed
- Conditions
- Sarcopenia
- Interventions
- Behavioral: Resistance exercise
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 126
- Registration Number
- NCT02942992
- Locations
- 🇺🇸
Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences, Chicago, Illinois, United States
PostNAPS: FI, Nutrition, and Psychosocial Health Among Women of Mixed HIV Status and Their Infants in Gulu, Uganda
Completed
- Conditions
- Maternal and Child HealthNutritionHIVPsychosocial HealthFood Insecurity
- First Posted Date
- 2016-10-05
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 246
- Registration Number
- NCT02925429
The PreNAPS Study: FI, Nutrition, and Psychosocial Health Outcomes at Gulu Regional Referral Hospital
Completed
- Conditions
- HIVPregnancy
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 403
- Registration Number
- NCT02922829
- Locations
- 🇺🇸
Northwestern University, Evanston, Illinois, United States
IV Tranexamic Acid Prior to Hysterectomy
Early Phase 1
Completed
- Conditions
- HysterectomyBlood Loss, Surgical
- Interventions
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 71
- Registration Number
- NCT02911831
- Locations
- 🇺🇸
Northwestern University - Northwestern Medicine, Lavin Family Pavillion, Chicago, Illinois, United States
Stellate Ganglion Blockade in Post-Menopausal Women
Phase 2
Suspended
- Conditions
- Hot FlushesHot FlashesVasomotor Symptoms
- Interventions
- Drug: Stellate Ganglion Block Injection with BupivicaineDrug: Saline injection
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 160
- Registration Number
- NCT02907983
- Locations
- 🇺🇸
Paul C. Fitzgerald, Chicago, Illinois, United States
🇺🇸Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Brain Morphometry in OA Patients Treated With Duloxetine
Not Applicable
Completed
- Conditions
- PainOsteoarthritis
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 21
- Registration Number
- NCT02903238
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2
Completed
- Conditions
- Recurrent Ovarian CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
- Interventions
- First Posted Date
- 2016-09-15
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 45
- Registration Number
- NCT02901899
- Locations
- 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States
Health Effects of Mentoring
Not Applicable
Completed
- Conditions
- Cardiovascular Health
- Interventions
- Behavioral: Mentoring
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 55
- Registration Number
- NCT02900638
- Locations
- 🇺🇸
Northwestern University, Evanston, Illinois, United States
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
Phase 2
Terminated
- Conditions
- Stage IV Inflammatory Breast CarcinomaRecurrent Inflammatory Breast CarcinomaStage IV Breast CancerHER2/Neu Negative
- Interventions
- Biological: IpilimumabOther: Laboratory Biomarker AnalysisBiological: Nivolumab
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2020-07-16
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 3
- Registration Number
- NCT02892734
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath